SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001567619-15-001467
Filing Date
2015-11-06
Accepted
2015-11-06 07:15:34
Documents
5
Period of Report
2015-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K s001093x2_8k.htm 8-K 18993
2 EXHIBIT 99.1 s001093x2_ex99-1.htm EX-99.1 19291
3 GRAPHIC logo_edge.jpg GRAPHIC 5640
4 GRAPHIC s001093x2_ex991-image001.jpg GRAPHIC 151288
5 GRAPHIC s001093x2_ex991-image002.jpg GRAPHIC 87427
  Complete submission text file 0001567619-15-001467.txt   376397
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 151202422
SIC: 2834 Pharmaceutical Preparations